Sharvil Patel, deputy managing director of Cadila Healthcare, is working to achieve $3 bn in sales by 2015
After completing his graduation in science, Sharvil Patel, son of Pankaj Patel, chairman and managing director of Cadila Healthcare Ltd (also known as Zydus Cadila), had to choose between pursuing his masters in management and research. He settled for research and did his doctorate from the University of Sunderland in the UK on breast cancer research at John Hopkins Bayview Medical Center, in the US. That didn’t deter him from becoming a key business strategist in the group. Two years ago, he was the chief negotiator for the group’s strategic deal with Abbott Laboratories Ltd to market Zydus drugs in emerging economies. He declines to say anything about this deal due to the confidentiality agreement between the two companies.